Sign in

CIK 0001984086

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Septerna, Inc.

Sign in to watch
Ticker
SEPN
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
843891440
Phone
+1 650-338-3533
Business address
250 EAST GRAND AVENUE, SUITE 65, SOUTH SAN FRANCISCO, CA, 94080
  1. 4 Derivatives Options or other derivatives
  2. 4 Planned sale SVP, Drug Discovery sold 15,000 shares at an average $35.51 ($532,582)
  3. 4 Planned sale Chief People Officer sold 6,250 shares at $35.08 ($219,224)
  4. 4 Planned sale Chief People Officer sold 5,935 shares at an average $28.93 ($171,682)
  5. 4 Planned sale Chief People Officer sold 11,798 shares at $30.06 ($354,656)
  6. 4 Planned sale President and COO sold 4,000 shares at an average $24.34 ($97,343)
  7. 4 Planned sale Chief People Officer sold 70,453 shares at an average $28.10 ($1,979,838)
  8. 4 Planned sale President and COO sold 4,000 shares at an average $28.97 ($115,860)
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market sale SVP, Drug Discovery sold 3,501 shares at $18.06 ($63,223)
  19. 4 Derivatives Options or other derivatives
  20. 3 Insider Initial Statement of Ownership

Page 2 of 5 · 82 filings